Mari M. Kitahata

16.2k total citations
144 papers, 5.3k citations indexed

About

Mari M. Kitahata is a scholar working on Infectious Diseases, Emergency Medicine and Epidemiology. According to data from OpenAlex, Mari M. Kitahata has authored 144 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Infectious Diseases, 59 papers in Emergency Medicine and 54 papers in Epidemiology. Recurrent topics in Mari M. Kitahata's work include HIV/AIDS Research and Interventions (86 papers), HIV-related health complications and treatments (59 papers) and HIV Research and Treatment (44 papers). Mari M. Kitahata is often cited by papers focused on HIV/AIDS Research and Interventions (86 papers), HIV-related health complications and treatments (59 papers) and HIV Research and Treatment (44 papers). Mari M. Kitahata collaborates with scholars based in United States, Canada and Puerto Rico. Mari M. Kitahata's co-authors include Heidi M. Crane, Stephen E. Van Rompaey, Michael J. Mugavero, Michael S. Saag, Benigno Rodríguez, James H. Willig, Richard D. Moore, Robert Harrington, Paul K. Crane and William C. Mathews and has published in prestigious journals such as New England Journal of Medicine, JAMA and Blood.

In The Last Decade

Mari M. Kitahata

136 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mari M. Kitahata United States	37	3.5k	2.2k	1.6k	1.5k	727	144	5.3k
David A. Wohl United States	42	4.0k 1.2×	1.9k 0.9×	1.8k 1.1×	1.7k 1.1×	1.1k 1.5×	215	6.4k
Jeanne Keruly United States	41	4.0k 1.1×	3.1k 1.4×	1.8k 1.1×	1.2k 0.8×	775 1.1×	126	5.7k
Colette Smith United Kingdom	40	3.7k 1.0×	2.8k 1.3×	1.6k 1.0×	1.6k 1.1×	377 0.5×	233	6.9k
Sundhiya Mandalia United Kingdom	42	2.9k 0.8×	1.6k 0.8×	1.6k 1.0×	851 0.6×	600 0.8×	157	5.7k
Michael A. Horberg United States	37	3.0k 0.9×	2.2k 1.0×	1.2k 0.7×	1.6k 1.1×	636 0.9×	185	5.7k
Edgar T. Overton United States	44	2.5k 0.7×	1.9k 0.9×	1.5k 0.9×	2.5k 1.7×	399 0.5×	194	5.6k
Kholoud Porter United Kingdom	39	3.5k 1.0×	1.8k 0.8×	2.5k 1.6×	1.0k 0.7×	306 0.4×	138	4.6k
Jane Anderson United Kingdom	39	3.3k 0.9×	2.2k 1.0×	1.1k 0.7×	1.2k 0.8×	923 1.3×	247	5.3k
Mary Culnane United States	24	4.5k 1.3×	2.3k 1.1×	1.9k 1.2×	1.1k 0.7×	1.1k 1.4×	38	6.7k
Kate Buchacz United States	38	3.2k 0.9×	2.2k 1.0×	1.1k 0.7×	1.5k 1.0×	595 0.8×	130	4.6k

Countries citing papers authored by Mari M. Kitahata

Since Specialization

Citations

This map shows the geographic impact of Mari M. Kitahata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari M. Kitahata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari M. Kitahata more than expected).

Fields of papers citing papers by Mari M. Kitahata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari M. Kitahata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari M. Kitahata. The network helps show where Mari M. Kitahata may publish in the future.

Co-authorship network of co-authors of Mari M. Kitahata

This figure shows the co-authorship network connecting the top 25 collaborators of Mari M. Kitahata. A scholar is included among the top collaborators of Mari M. Kitahata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari M. Kitahata. Mari M. Kitahata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hudgens, Michael G., Haidong Lu, Stephen R. Cole, et al.. (2023). Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine. American Journal of Epidemiology. 192(8). 1341–1349. 1 indexed citations

Fredericksen, Rob J., Laura E. Gibbons, Robin M. Nance, et al.. (2021). Impact and correlates of sub-optimal social support among patients in HIV care. AIDS Care. 33(9). 1178–1188. 9 indexed citations

Kasaie, Parastu, Elizabeth Humes, Jinbing Zhang, et al.. (2021). Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States. Annals of Epidemiology. 65. 46–55. 7 indexed citations

Kim, H. Nina, Chad J. Achenbach, Edward R. Cachay, et al.. (2021). Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV. HIV Medicine. 23(6). 620–628. 1 indexed citations

Harding, Barbara N, Bridget M. Whitney, Robin M. Nance, et al.. (2020). Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study. BMJ Open. 10(3). e031487–e031487. 6 indexed citations

Harding, Barbara N, Bridget M. Whitney, Robin M. Nance, et al.. (2020). Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study. BMC Infectious Diseases. 20(1). 238–238. 28 indexed citations

Rebeiro, Peter F., Peter F. Rebeiro, Cathy A. Jenkins, et al.. (2019). LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care. Open Forum Infectious Diseases. 6(Supplement_2). S996–S997. 13 indexed citations

Althoff, Keri N., Cherise Wong, Brenna Hogan, et al.. (2019). Mind the gap: observation windows to define periods of event ascertainment as a quality control method for longitudinal electronic health record data. Annals of Epidemiology. 33. 54–63. 6 indexed citations

Nance, Robin M., Heidi M. Crane, Corey Ritchings, et al.. (2018). Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors. AIDS Research and Human Retroviruses. 34(11). 916–921. 3 indexed citations

10.

Edwards, Jessie K., Stephen R. Cole, Richard D. Moore, et al.. (2018). Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula. American Journal of Epidemiology. 187(8). 1808–1816. 5 indexed citations

11.

Tirschwell, David, Felicia C. Chow, Kyra J. Becker, et al.. (2017). Incidence of Stroke in the US Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) Cohort (S51.008). Neurology. 88(16_supplement). 2 indexed citations

12.

Drozd, Daniel R., Susan M. Graham, Heidi M. Crane, et al.. (2016). Short Communication: Effect of Antiretroviral Therapy on Circulating Damage-Associated Molecular Pattern Molecules and CD4 Immune Reconstitution in HIV-Infected Individuals. AIDS Research and Human Retroviruses. 32(9). 876–878. 3 indexed citations

13.

Wolf, Elizabeth R., Joshua T. Herbeck, Mari M. Kitahata, et al.. (2016). Short Communication: Phylogenetic Evidence of HIV-1 Transmission Between Adult and Adolescent Men Who Have Sex with Men. AIDS Research and Human Retroviruses. 33(4). 318–322. 17 indexed citations

14.

Edwards, Jessie K., Stephen R. Cole, Jeffrey N. Martin, et al.. (2015). Dynamic Visual Display of Treatment Response in HIV-Infected Adults. Clinical Infectious Diseases. 61(1). e1–e4. 5 indexed citations

15.

Crane, Heidi M., Shireesha Dhanireddy, Christian B. Ramers, et al.. (2012). Hepatitis A vaccination among human immuno- deficiency virus (HIV)-infected adults: Current evidence and unanswered questions. Journal of AIDS and HIV Research. 5(3). 90–100. 1 indexed citations

16.

Scott, John D., Anna Wald, Mari M. Kitahata, et al.. (2009). Hepatitis C Virus Is Infrequently Evaluated and Treated in an Urban HIV Clinic Population. AIDS Patient Care and STDs. 23(11). 925–929. 23 indexed citations

17.

Kitahata, Mari M.. (2008). Initiating Rather than Deferring Haart at a CD4+ Count Between 351-500 Cells/mm 3 is Associated with Improved Survival. 46th Annual Meeting. 3 indexed citations

18.

Crane, Heidi M., et al.. (2008). The Effect of Mental Illness, Substance Use, and Treatment for Depression on the Initiation of Highly Active Antiretroviral Therapy among HIV-Infected Individuals. AIDS Patient Care and STDs. 22(3). 233–243. 122 indexed citations

19.

Crane, Heidi M., Stephen E. Van Rompaey, & Mari M. Kitahata. (2007). Initiating Highly Active Antiretroviral Therapy with Newer Protease Inhibitors Is Associated with Better Survival Compared to First-Generation Protease Inhibitors or Nevirapine. AIDS Patient Care and STDs. 21(12). 920–929. 8 indexed citations

20.

Crane, Heidi M., et al.. (2006). A Single-Item Measure of Health-Related Quality-of-Life for HIV-Infected Patients in Routine Clinical Care. AIDS Patient Care and STDs. 20(3). 161–174. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact